The rigorous control of ophthalmic health products in China is centralized under the National Medical Products Administration (NMPA), which oversees the classification, registration, and post-market surveillance of drugs, medical devices, and health supplements. For supplements, the NMPA defines strict standards for ingredient usage, dose limits, and efficacy claims, classifying them distinctly...